Abstract
In general, data are lacking to guide the optimal obstetric management of asthma, and recommendations are based on extrapolation of data from other clinical settings and expert opinion. Gravida should be offered influenza vaccination as appropriate. Those with persistent asthma are at risk for pregnancy complications and may benefit from increased fetal surveillance, including fetal nonstress testing and estimation of fetal growth by ultrasound. Adverse outcomes may be more common if asthma severity is underestimated and the asthma undertreated. Stopping asthma medications in the first trimester can cause exacerbations resulting in an increased risk of fetal malformations. It is safer for pregnant women to be treated with asthma medications than it is for them to have asthma symptoms and exacerbations. Identifying and controlling or avoiding triggering factors such as allergens and irritants, particularly tobacco smoke, can lead to improved maternal well-being with less need for medication. The goal of asthma therapy is maintenance of near normal pulmonary function. Women with significant allergic disease should be evaluated prior to pregnancy, so that skin testing, challenge procedures, or other exposures that might be necessary for definitive diagnosis can be safely performed. A plan for management during pregnancy can then be formulated. Anaphylaxis is a rare but potentially deadly complication for both mother and baby. The prognosis is dependent upon early diagnosis and rapid medical management. Cesarean delivery can be life-saving for the fetus and may enhance maternal survival. In the case of perimortem anaphylaxis, fetal outcome is optimized if emergent cesarean delivery can be accomplished within 5 min and can also increase maternal survival due to reduced aortocaval compression by the uterus and increased maternal cardiac output. Anaphylaxis remote from term can cause difficult management and ethical decisions regarding early delivery.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
National Asthma Education and Prevention Program Expert Panel Report. Managing asthma during pregnancy: recommendations for pharmacologic treatment—2004 update. J Allergy Clin Immunol. 2005;115:34–46.
American College of Obstetricians and Gynecologists. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008 Asthma in pregnancy. Obstet Gynecol. 2008;111:457–64.
National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma—full report 2007. URL: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed 2-1-18.
Wolsk HM, Harshfield BJ, Laranjo N, Carey VJ, O’Connor G, Sandel M, Strunk RC, Bacharier LB, Zeiger RS, Schatz M, Hollis BW, Weiss ST, Litonjua AA. Vitamin D supplementation in pregnancy, prenatal 25(OH)D levels, race, and subsequent asthma or recurrent wheeze in offspring: secondary analyses from the vitamin D antenatal asthma reduction trial. J Allergy Clin Immunol. 2017;140:1423–9.e5. UI: 28285844
Belanger K, Hellenbrand ME, Holford TR, et al. Effect of pregnancy on maternal asthma symptoms and medication use. Obstet Gynecol. 2010;3:559–67.
Enriquez R, Wu P, Griffin M, et al. Cessation of asthma medication in early pregnancy. Am J Obstet Gynecol. 2006;195:149–53.
Mendola P, Laughon K, Männistö T, et al. Obstetric complications among US women with asthma. Am J Obstet Gynecol. 2013;208(127):e1–8.
Briggs G, Freeman R, editors. Drugs in pregnancy and lactation. 10th ed. Philadelphia: Wolters Kluwer; 2015.
Bracken MB, Triche EW, Belanger K, et al. Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies. Obstet Gynecol. 2003;1024:739.
Dombrowski MP, Schatz M, Wise R, for the National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network and the National Heart, Lung, and Blood Institute (NHLBI), et al. Asthma during pregnancy. Obstet Gynecol. 2004;103:5.
Namazy JA, Chambers C, Schatz M. Safety of therapeutic options for treating asthma in pregnancy. Expert Opin Drug Saf. 2014;13:1613.
Schatz M, Dombrowski MP, Wise R, for the NICHD Maternal-Fetal Medicine Units Network and the NHLBI, et al. The relationship of asthma medication use to perinatal outcomes. J Allergy Clin Immunol. 2004;113:104.
Schatz M, Dombrowski MP. Asthma in pregnancy. N Engl J Med. 2009;360:1862–9.
Towers CV, Briggs GG, Rojas JA. The use of prostaglandin E2 in pregnant patients with asthma. Am J Obstet Gynecol. 2004;190:1777.
Booker WA, Huang Y, Ananth CV, Wright JD, et al. Administration of Carboprost and intravenous labetolol to asthmatic patients during delivery hospitalizations. Am J Obstet Gynecol. 2018;218:Supp 51.
Schatz M, Simons E, Dombrowski M. Anaphylaxis in pregnant and breastfeeding women. In: Basow DS, editor. UpToDate. Waltham: UpToDate; 2017.
Mulla ZD, Ebrahim MS, Gonzalez JL. Anaphylaxis in the obstetric patient: analysis of a statewide hospital discharge database. Ann Allergy Asthma Immunol. 2010;104:55–9.
Hepner D, Castells M, Mouton-Faivre C, Dewachter P. Anaphylaxis in the clinical setting of obstetric anesthesia: a literature review. Anesth Analg. 2013;117:1357–67.
Berenguer A, Couto A, Brites V, Fernandes R. Anaphylaxis in pregnancy: a rare cause of neonatal mortality. BMJ Case Rep. Published online: https://doi.org/10.1136/bcr-2012-007055.
Simons F, Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol. 2012;130:597–606.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Dombrowski, M. (2019). Obstetric Management of High-Risk Asthmatic, Allergic Patients and Anaphylaxis. In: Namazy, J., Schatz, M. (eds) Asthma, Allergic and Immunologic Diseases During Pregnancy. Springer, Cham. https://doi.org/10.1007/978-3-030-03395-8_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-03395-8_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-03394-1
Online ISBN: 978-3-030-03395-8
eBook Packages: MedicineMedicine (R0)